| Name |
Zassida 25 mg/ml prašak za suspenziju za injekciju |
| Marketing Authorisation Number |
HR-H-083919150 |
| Active Substance |
azacitidin |
| Composition |
Svaka bočica s praškom sadrži 100 mg ili 150 mg azacitidina. Nakon rekonstitucije jedan ml suspenzije sadrži 25 mg azacitidina. |
| Pharmaceutical Form |
prašak za suspenziju za injekciju |
| Manufacturer |
AqVida GmbH, Hamburg, Njemačka |
| Marketing Authorisation Holder |
Zentiva k.s., U Kabelovny 130, Dolni Mecholupy, Prag 10, Češka |
| Marketing Authorisation Date |
07.01.2021 |
| MA Period of Validity |
07.01.2026 |
| Classification Number |
UP/I-530-09/19-01/273 |
| Registration Number |
381-12-01/38-21-04 |
| Prescription |
na recept |
| Type of prescription |
ograničeni recept
|
| Distribution |
u ljekarni |
| Advertising to general public |
zabranjeno |
| ATC Code |
L01BC07 |
| Medicinal product marketed in the Croatia |
Da |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
